Betamethasone Dipropionate 0.05% Cream

DRUG3 trials

Sponsors

Padagis LLC, MC2 Therapeutics, Pakistan Institute of Medical Sciences

Conditions

HealthyPsoriasis (PsO)Vasoconstriction

Phase 1

Evaluation of the Vasoconstriction Properties of MC2-01 Cream

CompletedNCT03758365

MC2 TherapeuticsVasoconstriction

Start: 2018-11-05End: 2018-11-23Updated: 2020-01-09

Phase 4

Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis

Not yet recruitingNCT07635043

Pakistan Institute of Medical SciencesPsoriasis (PsO)

Start: 2026-08-01End: 2026-11-30Target: 120Updated: 2026-06-09

Unknown Phase

Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams

CompletedNCT00800293

Padagis LLCHealthy

Start: 2002-12-31End: 2003-01-31Updated: 2021-10-18